OGDEN CHRISTOPHER (See Remarks) sold 6.1% of their position (19.32K shares) of CYTOMX THERAPEUTICS, INC. on the open market
Open‑market sale worth $124.1K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/19/2026ACC: 0001610717-26-000122
Officer· See Remarks
Since Feb 2022
-19.32K
Net shares
Net seller
$124.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
19.32K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−19.32K
Price / share
$6.42
Trade value
$124.11K
% of position
6.1%
3/17/2026
316.27K→296.95K
Total
Net shares
−19.32K
Net value
-$124.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/17/2026 | S · Sale | −19.32K | $6.42 | $124.11K | 6.1% | 316.27K | 296.95K |
| Total | −19.32K | -$124.11K | ||||||
Derivative Transactions0
No derivative transactions reported